Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Considerations for development of therapies for cutaneous neurofibroma
Sharad K. Verma, Vincent M. Riccardi, Scott R. Plotkin, et al.
Neurology (2018) Vol. 91, Iss. 2_Supplement_1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The Diagnosis and Management of Neurofibromatosis Type 1
Ina Ly, Jaishri O. Blakeley
Medical Clinics of North America (2019) Vol. 103, Iss. 6, pp. 1035-1054
Closed Access | Times Cited: 177
Cutaneous neurofibromas
Nicolás Ortonne, P. Wolkenstein, Jaishri O. Blakeley, et al.
Neurology (2018) Vol. 91, Iss. 2_Supplement_1
Open Access | Times Cited: 96
Management of cutaneous neurofibroma: current therapy and future directions
Bahir Chamseddin, Lu Q. Le
Neuro-Oncology Advances (2019) Vol. 2, Iss. Supplement_1, pp. i107-i116
Open Access | Times Cited: 35
Cutaneous neurofibromas: patients’ medical burden, current management and therapeutic expectations: results from an online European patient community survey
Marlène Guiraud, Athmane Bouroubi, Roxane Beauchamp, et al.
Orphanet Journal of Rare Diseases (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Current and Emerging Imaging Techniques for Neurofibromatosis Type 1–Associated Cutaneous Neurofibromas
Yingjoy Li, Jaishri O. Blakeley, Ina Ly, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 8, pp. 1397-1405
Open Access | Times Cited: 10
Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
Helena Mazuelas, Míriam Magallón-Lorenz, Itziar Uriarte-Arrázola, et al.
JCI Insight (2024)
Open Access | Times Cited: 3
Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1
Ana M. Cieza Rivera, Carlos Lobato Fuertes, Tania Fernández‐Villa, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1
Bahir Chamseddin, La’Nette Hernandez, Dezehree Solorzano, et al.
JCI Insight (2019) Vol. 4, Iss. 11
Open Access | Times Cited: 29
Characterization of health concerns in people with neurofibromatosis type 1
Jane Fleming, Oliver Morgan, Claire Wong, et al.
Molecular Genetics & Genomic Medicine (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 12
A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening
Huyen Thi Lam Nguyen, Emily Kohl, Jessica Bade, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 5, pp. 100772-100772
Open Access | Times Cited: 2
Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination
Brendan J. Quirk, Edit Olasz, Suresh N. Kumar, et al.
Photobiomodulation Photomedicine and Laser Surgery (2021) Vol. 39, Iss. 6, pp. 411-417
Open Access | Times Cited: 13
Current concepts of neurofibromatosis type 1: pathophysiology and treatment
Jaemin Choi, Sungbin An, So Young Lim
Archives of Craniofacial Surgery (2022) Vol. 23, Iss. 1, pp. 6-16
Open Access | Times Cited: 9
Clinical trial design for cutaneous neurofibromas
Ashley Cannon, Kurt Jarnagin, Bruce R. Korf, et al.
Neurology (2018) Vol. 91, Iss. 2_Supplement_1
Open Access | Times Cited: 12
Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors
Omar Rabab’h, Abeer Gharaibeh, Ali Al-Ramadan, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3880-3880
Open Access | Times Cited: 9
Neurofibromatoses
Justin T. Jordan, Scott R. Plotkin
Hematology/Oncology Clinics of North America (2021) Vol. 36, Iss. 1, pp. 253-267
Closed Access | Times Cited: 9
Validating Techniques for Measurement of Cutaneous Neurofibromas
Raquel Thalheimer, Vanessa L. Merker, Ina Ly, et al.
Neurology (2021) Vol. 97, Iss. 7_Supplement_1
Open Access | Times Cited: 8
The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis
Chih‐Kai Hsu, Rafael Denadai, Chun‐Shin Chang, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 558-558
Open Access | Times Cited: 5
Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1
Lisa Oliveira, Mauro Geller, Karin Soares Cunha, et al.
Heliyon (2021) Vol. 7, Iss. 3, pp. e06518-e06518
Open Access | Times Cited: 6
cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults
L. Fertitta, Kavita Y. Sarin, Christina Bergqvist, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 11, pp. 2226-2232.e1
Open Access | Times Cited: 2
A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas
Jaishri O. Blakeley, Lu Q. Le, Sang Yong Lee, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 8, pp. 1351-1357
Open Access | Times Cited: 2
Therapeutic Development in Neurofibromatosis
Mina Lobbous, Bruce R. Korf
IntechOpen eBooks (2019)
Open Access | Times Cited: 4
A rapid platform for 3D patient-derived cutaneous neurofibroma organoid establishment and screening
Huyen Thi Lam Nguyen, Emily Kohl, Jessica Bade, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Ex-vivo patient-derived explant model for neurofibromatosis type 1-related cutaneous neurofibromas
Jamie Grit, Lisa Turner, Curt J. Essenburg, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 9, pp. 2052-2065.e8
Closed Access
Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods
Patricia M. Richey, Margaret M. Funk, Fernanda H. Sakamoto, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 4, pp. 767-774
Closed Access | Times Cited: 1
Impact of Neurofibromatosis Type 1 on Quality of Life Using the Skindex-29 Questionnaire Quality of Life in Nf1
Ana M. Cieza Rivera, Carlos Lobato Fuertes, Tania Fernández‐Villa, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top